Marc Penn
Founder at Cleveland HeartLab, Inc.
Profile
Marc S.
Penn is the founder of Juventas Therapeutics, Inc. (founded in 2007), Cleveland HeartLab, Inc. (founded in 2009), and SironRX Therapeutics, Inc. (founded in 2010).
He held the position of Director & Chief Medical Officer at Juventas Therapeutics, Inc. from 2013 to 2014, Chief Medical Officer at Cleveland HeartLab, Inc. from 2009 to present, and Chief Medical Officer at SironRX Therapeutics, Inc. from 2010 to 2014.
Dr. Penn currently holds the position of Director & Chief Medical Officer at Diasome Pharmaceuticals, Inc., Director at Rhythm Therapeutics, Inc., Research Director at Summa Health System (Ohio), Director at SnappSkin, Inc., Chief Marketing Officer & Director at Keystone Bio, Inc., and Professor at Northeast Ohio Medical University.
He previously held the position of Director at Cardiovip, Inc. from 2012 to 2014, Venture Partner at Oakwood Medical Investors, Clinical Partner at Foundation Medical Partners from 2009 to 2011, Chief Medical Officer at PrognostiX, Inc., and Chief Medical Officer at Kenwood Health Group.
Dr. Penn received his doctorate degree from Case Western Reserve University in 1994 and 1989, and his undergraduate and graduate degrees from Case Western Reserve University.
Marc Penn active positions
| Companies | Position | Start |
|---|---|---|
Cleveland HeartLab, Inc.
 Cleveland HeartLab, Inc. Medical/Nursing ServicesHealth Services Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH. | Founder | 2008-12-31 |
Summa Health System (Ohio)
 Summa Health System (Ohio) Hospital/Nursing ManagementHealth Services Summa Health System, Inc. provides integrated and coordinated care services. It offers medical, specialized, support, and testing services. The company was founded in 1989 and is headquartered in Akron, OH. | Chief Tech/Sci/R&D Officer | - |
| Northeast Ohio Medical University | Corporate Officer/Principal | - |
| SnappSkin, Inc. | Director/Board Member | - |
| Rhythm Therapeutics, Inc. | Director/Board Member | - |
Diasome Pharmaceuticals, Inc.
 Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH. | Chief Tech/Sci/R&D Officer | - |
Keystone Bio, Inc.
 Keystone Bio, Inc. BiotechnologyHealth Technology Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO. | Director/Board Member | - |
Former positions of Marc Penn
| Companies | Position | End |
|---|---|---|
| Cardiovip, Inc. | Director/Board Member | 2013-12-31 |
Foundation Medical Partners
 Foundation Medical Partners Investment ManagersFinance Founded in 2001, Foundation Medical Partners is a venture capital firm located in Rowayton, Connecticut. The firm is affiliated with the Cleveland Clinic | Private Equity Investor | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Training of Marc Penn
| Case Western Reserve University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diasome Pharmaceuticals, Inc. operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes. It focuses on the clinical and commercial development of breakthrough therapies for diabetes and obesity. The company’s technology platform is based on the use of its proprietary Hepatocyte Directed Vesicle or HDV, nanotechnology to deliver a wide range of critically necessary hormones and drugs to the liver, the body’s primary site of glucose storage. The firm’s HDV system is designed to fundamentally improve the way in which insulin works in people with diabetes by enabling much greater amounts of injected insulin to reach hepatocytes, the liver’s glucose storing cells. The company was founded by Len Rosenberg, Lance Converse, W. Blair Geho and Robert Geho in 2004 and is headquartered in Cleveland, OH. | Health Technology |
| Cardiovip, Inc. | |
| Rhythm Therapeutics, Inc. | Health Technology |
Oakwood Medical Investors
 Oakwood Medical Investors Investment ManagersFinance Oakwood Medical Investors (Oakwood Medical Investors) is a venture capital firm founded in 1997 by Raul Perez. The firm is headquartered in Louis, Missouri. | Finance |
Foundation Medical Partners
Foundation Medical Partners Investment ManagersFinance Founded in 2001, Foundation Medical Partners is a venture capital firm located in Rowayton, Connecticut. The firm is affiliated with the Cleveland Clinic | Finance |
Summa Health System (Ohio)
Summa Health System (Ohio) Hospital/Nursing ManagementHealth Services Summa Health System, Inc. provides integrated and coordinated care services. It offers medical, specialized, support, and testing services. The company was founded in 1989 and is headquartered in Akron, OH. | Health Services |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH. | Health Services |
PrognostiX, Inc.
 PrognostiX, Inc. Pharmaceuticals: MajorHealth Technology PrognostiX, Inc. discovers and develops biomarker technologies. The firm also offers cardiovascular and inflammatory biomarkers. The company was founded in 2004 and is headquartered in Cleveland, OH. | Health Technology |
Cleveland HeartLab, Inc.
Cleveland HeartLab, Inc. Medical/Nursing ServicesHealth Services Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH. | Health Services |
SironRX Therapeutics, Inc.
 SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services SironRX Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. Its technology is stromal cell-derived factor-1 is a naturally occurring chemokine that is rapidly over-expressed in response to tissue injury, particularly during ischemia. The firm is developing novel therapies that promote wound repair and prevent scarring of dermal wounds. The company was founded by Marc S. Penn and Rahul Aras in 2010 and is headquartered in Cleveland, OH. | Health Services |
| Kenwood Health Group | |
| SnappSkin, Inc. | Miscellaneous |
Keystone Bio, Inc.
Keystone Bio, Inc. BiotechnologyHealth Technology Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO. | Health Technology |
- Stock Market
- Insiders
- Marc Penn
